Voyager Therapeutics, Inc. (NASDAQ:VYGR – Get Rating) – Analysts at Wedbush issued their Q1 2024 earnings per share estimates for Voyager Therapeutics in a research report issued on Tuesday, May 9th. Wedbush analyst L. Chico forecasts that the company will post earnings per share of ($0.67) for the quarter. The consensus estimate for Voyager Therapeutics’ […]
Voyager Therapeutics, Inc. (NASDAQ:VYGR – Get Rating) shares passed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $7.65 and traded as low as $7.61. Voyager Therapeutics shares last traded at $7.91, with a volume of 156,006 shares changing hands. Wall Street Analyst Weigh […]
Voyager Therapeutics (NASDAQ:VYGR – Get Rating) was downgraded by stock analysts at StockNews.com from a “buy” rating to a “hold” rating in a report issued on Friday. Separately, Oppenheimer initiated coverage on shares of Voyager Therapeutics in a research report on Thursday, March 9th. They issued an “outperform” rating and a $14.00 price target for […]
Voyager Therapeutics, Inc. (NASDAQ:VYGR – Get Rating) COO Robin Swartz sold 3,654 shares of the business’s stock in a transaction that occurred on Monday, March 20th. The shares were sold at an average price of $7.76, for a total value of $28,355.04. Following the completion of the sale, the chief operating officer now directly owns […]